BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34980442)

  • 1. [Cutaneous Rosai-Dorfman disease with lack of BRAF-V600, KRAS or NRAS mutations: A reactive or neoplastic disorder?].
    Machado I; Alcacer Fernández-Coronado J; Requena C; Través V; Latorre Martínez N; Ortega J; Requena L; Alcacer García J
    Rev Esp Patol; 2022; 55(1):52-56. PubMed ID: 34980442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosai-Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation.
    Shanmugam V; Margolskee E; Kluk M; Giorgadze T; Orazi A
    Head Neck Pathol; 2016 Sep; 10(3):394-9. PubMed ID: 26922062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous adult xanthogranuloma with a small portion of BRAF
    Ishikawa M; Endo Y; Uehara A; Suto M; Yasuda M; Motegi SI; Ishikawa O
    J Dermatol; 2019 Feb; 46(2):161-165. PubMed ID: 30536719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRAS 117N positive Rosai-Dorfman disease with atypical features.
    Jafri ZA; Reddy SP; Cassarino DS
    J Cutan Pathol; 2021 Jan; 48(1):147-150. PubMed ID: 32974961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF mutation leading to central nervous system rosai-dorfman disease.
    Richardson TE; Wachsmann M; Oliver D; Abedin Z; Ye D; Burns DK; Raisanen JM; Greenberg BM; Hatanpaa KJ
    Ann Neurol; 2018 Jul; 84(1):147-152. PubMed ID: 30014527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary intraosseous Rosai-Dorfman disease: a clinicopathological analysis of fourteen cases].
    Dong RF; Gong LH; Zhang W; Li L; Sun XQ; Zhang M; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):904-909. PubMed ID: 32892555
    [No Abstract]   [Full Text] [Related]  

  • 7. How I Diagnose Rosai-Dorfman Disease.
    Ravindran A; Rech KL
    Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent central nervous system Rosai-Dorfman disease with KRAS mutation: a case report.
    Wang Q; Ren H; Zheng L; Wang J; Zhong D
    Diagn Pathol; 2023 Feb; 18(1):21. PubMed ID: 36782249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated intracranial rosai-dorfman disease involving the meninges: report of a rare case.
    Bhat A; Kupanur SS; Geethamani V
    Turk Neurosurg; 2015; 25(1):186-9. PubMed ID: 25640569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell analysis of a progressive Rosai-Dorfman disease affecting the cerebral parenchyma: a case report.
    Huang GH; Liu GL; Huang DZ; Diao XW; Lv SQ
    Acta Neuropathol Commun; 2024 May; 12(1):78. PubMed ID: 38769536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous Rosai-Dorfman disease: clinicopathological profiles, spectrum and evolution of 21 lesions in six patients.
    Wang KH; Chen WY; Liu HN; Huang CC; Lee WR; Hu CH
    Br J Dermatol; 2006 Feb; 154(2):277-86. PubMed ID: 16433797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cutaneous revelation of Rosai-Dorfman disease: 7 cases].
    Vuong V; Moulonguet I; Cordoliani F; Crickx B; Bezier M; Vignon-Pennamen MD; Flageul B; Bagot M; Petit A
    Ann Dermatol Venereol; 2013 Feb; 140(2):83-90. PubMed ID: 23395488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined histiocytosis of the Langerhans group (Langerhans cell histiocytosis and Erdheim-Chester disease) in a 64-year-old man with BRAF and NRAS mutations: a case report].
    Rodríguez-Duque MS; Martín Soler P; González Vela MC; Gómez Román JJ
    Rev Esp Patol; 2023; 56(3):186-190. PubMed ID: 37419557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosai-Dorfman-Destombes disease - histiocytic disorder with inflammatory manifestation.
    Adam Z; Adamová Z; Pour L; Řehák Z; Koukalová R; Král Z
    Klin Onkol; 2022; 35(4):262-170. PubMed ID: 35989082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facial cutaneous Rosai-Dorfman disease: a case report.
    Wongrat T; Sangmala S
    J Med Case Rep; 2024 Mar; 18(1):182. PubMed ID: 38532442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.
    Abla O; Jacobsen E; Picarsic J; Krenova Z; Jaffe R; Emile JF; Durham BH; Braier J; Charlotte F; Donadieu J; Cohen-Aubart F; Rodriguez-Galindo C; Allen C; Whitlock JA; Weitzman S; McClain KL; Haroche J; Diamond EL
    Blood; 2018 Jun; 131(26):2877-2890. PubMed ID: 29720485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare case of facial cutaneous Rosai-Dorfman disease clinically mimicking basal cell carcinoma followed by multiple myeloma after 2 years.
    Amir B; Amir A; Sheikh S
    J Med Life; 2024 Feb; 17(2):239-241. PubMed ID: 38813357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lethal intracranial Rosai-Dorfman disease of the brainstem diagnosed at autopsy.
    Imada H; Sakatani T; Sawada M; Matsuura T; Fukushima N; Nakano I
    Pathol Int; 2015 Oct; 65(10):549-53. PubMed ID: 26184902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosai-Dorfman disease and juvenile xanthogranuloma in a Thai boy: report of a case.
    Poklang V; Shuangshoti S; Chaipipat M; Nuchprayoon I; Shuangshoti S
    J Med Assoc Thai; 2006 Jan; 89(1):94-8. PubMed ID: 16583588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-needle aspiration specimens of 3 cases of intra-abdominal Rosai-Dorfman disease with comprehensive review of the literature.
    McIntire PJ; Kilic AI; Chen HH; Atieh M; Wojcik EM; Pambuccian SE
    J Am Soc Cytopathol; 2019; 8(4):190-205. PubMed ID: 31272602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.